GW Pharmaceuticals

^{Priced, Nasdaq: GWPH}

Develops and commercializes cannabinoid-based therapeutics.

Industry: Health Care

First Day Return: +0.9%

GWPH

Develops and commercializes cannabinoid-based therapeutics.

IPO News for GW Pharmaceuticals

Will it trade high? Cannabis biotech Zynerba Pharmaceuticals sets terms for $42 million IPO 07/23/15
Uncovering the cannabis cure: Zynerba Pharmaceuticals files for a $58 million IPO 06/30/15
US IPO Recap: Activity remains robust with five pricings, five setting terms and four new filers 05/06/13

IPO Data
IPO Date	05/01/2013
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$31
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.gwpharm.com
Headquarters	Wilshire, United Kingdom
Founded	1998
Employees at IPO	182

IPO News for GW Pharmaceuticals

GW Pharmaceuticals (GWPH) Performance